Haematologica (Feb 2024)

Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma

  • Maria Victoria Mateos,
  • Katja Weisel,
  • Evangelos Terpos,
  • Sossana Delimpasi,
  • Efstathios Kastritis,
  • Elena Zamagni,
  • Michel Delforge,
  • Enrique Ocio,
  • Eirini Katodritou,
  • Francesca Gay,
  • Alessandra Larocca,
  • Xavier Leleu,
  • Paula Rodriguez Otero,
  • Fredik Schjesvold,
  • Michele Cavo,
  • Meletios A. Dimopoulos

DOI
https://doi.org/10.3324/haematol.2023.284694
Journal volume & issue
Vol. 999, no. 1

Abstract

Read online

Not available.